find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
298
Clinical Trials
Breast Cancer Clinical Trials
Pilot
Accepting Patients
nct/study# NA / IOTA-STUDY
Investigating Obstacles To Treatment Adherence For Metastatic Breast Cancer
Learn More
Breast Cancer Clinical Trials
NA
Accepting Patients
nct/study# NA / U01-COTA-DATABASE
Optimizing Personalized Care Using Economic Studies Of Genomic Testing
Learn More
Breast Cancer Clinical Trials
Phase II
Accepting Patients
nct/study# NCT03487666 / 2017-1535-CA209-8CL
OXEL: A Pilot Study Of Immune Checkpoint Or Capecitabine Or Combination Therapy As Adjuvant Therapy For Triple Negative Breast Cancer With Residual Disease Following Neoadjuvant Chemotherapy
Learn More
Breast Cancer Clinical Trials
Phase II
Accepting Patients
nct/study# NCT02400658 / BREAST-IORT
A Prospective Multi-Site Single- Arm Phase II Study To Investigate Breast IORT – The Efficacy Of Single-Fraction Intraoperative Radiation Treatment Using A Multi-Lumen Balloon Applicator And In-Room CT Imaging For The Treatment Of Early-Stage Breast Cancer.
Learn More
Breast Cancer Clinical Trials
Ib/II
Active
nct/study# NCT04802759 / CO42867 - Morpheus BC
A Phase Ib/Ii, Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Treatment Combinations In Patients With Breast Cancer (Morpheus-Breast Cancer)
Learn More
Breast Cancer Clinical Trials
Ib/II
Accepting Patients
nct/study# NCT03424005 / CO40115 - Morpheus TNBC
A Phase Ib/Ii,Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Metastatic Triple-Negative Breast Cancer (Morpheus-Tnbc)
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.